Target intelligence / Profile preview

Pathogenic bacterium in gut lumen

Molecular classification
Other (not a single molecular family; encompasses various classes such as Gram-negative and Gram-positive bacteria, with diverse taxonomic families including Enterobacteriaceae, Bacteroidetes, Clostridiaceae, Vibrionaceae, Fusobacteriaceae, etc.)
01

Overview

Pathogenic bacteria in the gut lumen are a diverse group of microbial species that reside or invade the gastrointestinal tract and contribute to disease through mechanisms such as infection, toxin production, disruption of mucosal barriers, and induction of host inflammatory responses. They are distinct from commensal, beneficial gut bacteria, and their overgrowth or increased virulence often correlates with dysbiosis—an imbalance in the microbial community. Targeting these bacteria is central to the management of a wide variety of gut-related infectious and inflammatory diseases.

Other names
gut pathogensenteric pathogenspathogenic intestinal bacterium/bacteriaGI pathogenic bacteriainfectious gut bacteria
02

Mechanism of action

Direct antimicrobial action (cell wall synthesis inhibition, protein synthesis inhibition, DNA replication inhibition, etc.) Suppression of virulence factor expression Restoration of normal microbiota (competition/exclusion)

03

Biological functions

InfectionHost cell invasionToxin productionInflammation inductionImmune evasionCompetition with commensal microbiota
04

Disease associations

Infection (gastroenteritis, colitis, food poisoning)Inflammation (inflammatory bowel diseases)Liver disease complications (e.g., hepatic encephalopathy)Systemic diseases via translocation or gut barrier dysfunctionCancer (by promoting chronic inflammation)
05

Safety considerations

Antibiotic resistance (major issue with targeting gut pathogens)Disruption of normal flora (antibiotic-associated diarrhea, Clostridium difficile infection)Relapse or recurrence of infectionImmune overactivation/chronic inflammation
06

Interacting drugs

Antibiotics (ciprofloxacin, metronidazole, vancomycin, amoxicillin, etc.)

2 more in the full profile.

07

Biomarkers

Detection of pathogenic species (PCR, culture)Toxin detection (Clostridium difficile toxins, shiga toxin)Inflammatory markers (calprotectin, C-reactive protein)Fecal lipopolysaccharide (LPS) levels

Beyond the preview

Go deeper on Pathogenic bacterium in gut lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacterium in gut lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call